Results 121 to 130 of about 1,060 (168)
Some of the next articles are maybe not open access.

Visual compatibility of atosiban acetate with four drugs

American Journal of Health-System Pharmacy, 2005
Preterm delivery (before 37 completed weeks of gestation) is the major determinant of infant mortality.[1][1] Approved for use in European countries, atosiban is a new tocolytic indicated for the delay of imminent preterm birth in pregnant women with regular uterine contractions at a gestational ...
Swart, Eleonora L.   +3 more
openaire   +2 more sources

Atosiban and managing women in preterm labour

The Lancet
Lancet . 2025;405:955-957. doi: 10.1016/S0140-6736(25)00402-7. Preterm labor (PTL) is a significant cause of preterm birth (PTB) worldwide, which can cause substantial health challenges for neonates. Tocolysis can be used in some cases of PTL to delay birth. Recently, the use
Maureen, Makama, Joshua P, Vogel
openaire   +3 more sources

Atosiban

2007
Atosiban is a synthetic analog of oxytocin and acts as a competitive antagonist at the oxytocin receptor. Atosiban is used in the management of preterm labor (labor occurring before 37 weeks of gestation).
openaire   +1 more source

Atosiban

Reactions Weekly, 2022
openaire   +1 more source

Atosiban/misoprostol

Reactions Weekly, 2022
openaire   +1 more source

Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group.

American journal of obstetrics and gynecology, 2000
Patients admitted with an acute episode of preterm labor who respond to early intravenously administered tocolysis remain at risk of having subsequent episodes of preterm labor and preterm delivery. Several pharmacologic agents have been used in an attempt to reduce subsequent episodes of preterm labor, and all are associated with significant side ...
G J, Valenzuela   +11 more
openaire   +1 more source

Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Atosiban Study Group.

Obstetrics and gynecology, 1996
To evaluate the minimal effective dose regimen of the oxytocin antagonist atosiban in the treatment of acute preterm labor and the effect of a bolus on uterine activity within the first 2 hours compared with no bolus and the same infusion rate.A randomized, double-blind (except the ritodrine group), parallel group, multicenter study compared four ...
T M, Goodwin   +3 more
openaire   +1 more source

Atosiban

Reactions Weekly, 2017
openaire   +1 more source

Atosiban

Reactions Weekly, 2013
openaire   +1 more source

Home - About - Disclaimer - Privacy